All CompaniesPharmaceutical Preparations
INVA
Innoviva, Inc. Common Stock$21.64updated Jul 30, 2026
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
Total Trades
2
Politicians Trading
1
Last Traded
Mar 25, 2025
Price history
Congressional Trades
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| George WhitesidesD | Apr 23, 2025 | Mar 25, 2025 | Sell | $250,001 - $500,000 | +24.51% |
| George WhitesidesD | Apr 23, 2025 | Mar 24, 2025 | Sell | $50,001 - $100,000 | +24.87% |